Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
0.670
+0.001 (0.15%)
Jul 22, 2024, 9:35 AM EDT - Market open
Sensei Biotherapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$4.33
Upside
+546.27%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +497.01% | Jun 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +497.01% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +646.27% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Initiates $5 | Buy | Initiates | $5 | +646.27% | May 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +497.01% | Dec 4, 2023 |
Citigroup | Citigroup | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +795.52% | Dec 13, 2022 |
Oppenheimer | Oppenheimer | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +646.27% | Oct 3, 2022 |
Piper Sandler | Piper Sandler | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +1,392.54% | Mar 10, 2022 |
Berenberg | Berenberg | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 1, 2021 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 29, 2021 |
Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 1, 2021 |
Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 1, 2021 |